Healthcare DIVE August 8, 2024
Rebecca Pifer

The decision, disclosed Wednesday in a securities filing, is a sharp reversal to the pharmacy behemoth’s past commitment to building out its healthcare delivery offerings.

Dive Brief:

  • Walgreens is considering a full sale of its stake in VillageMD, after pouring billions of dollars into the unprofitable primary care chain. The decision, disclosed Wednesday in a securities filing, is a sharp reversal to the pharmacy behemoth’s past commitment to building out its healthcare delivery offerings.
  • Walgreens is “currently evaluating a variety of options” in light of VillageMD’s “substantial ongoing and expected future cash requirements,” the company said in the 8-K. “These options could include a sale of all or part of the VillageMD businesses, possible restructuring options and other strategic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Primary care, Provider, Trends
Related Articles:
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Does PBM Market Share Vary by Payer Type?
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
Pharma Pulse 9/13/24: AI Adoption for Clinical Trial Design, Comparing Biologics and Biosimilars & more

Share This Article